Mizzou's Bench-to-bedside Efforts Support Drug for a Neuromuscular Disorder With No Cure
April 14, 2026
April 14, 2026
COLUMBIA, Missouri, April 14 -- The University of Missouri issued the following news release:
* * *
Mizzou's bench-to-bedside efforts support a new drug for a neuromuscular disorder with no cure
The drug, ignaseclant, helped people with Charcot-Marie-Tooth disease in a clinical trial at Mizzou's NextGen Precision Health building.
*
The University of Missouri is at the forefront of developing a novel treatment to improve m . . .
* * *
Mizzou's bench-to-bedside efforts support a new drug for a neuromuscular disorder with no cure
The drug, ignaseclant, helped people with Charcot-Marie-Tooth disease in a clinical trial at Mizzou's NextGen Precision Health building.
*
The University of Missouri is at the forefront of developing a novel treatment to improve m . . .